Prophylactic Use of Myelopoietic Growth Factors in Children After Myelosuppressive Chemotherapy: Does It Pay?

This publication has 22 references indexed in Scilit:

• HAEMATOPOIETIC GROWTH FACTORS IN CHILDREN WITH NEUTROPENIA
  British Journal of Haematology, 2002
• Myelopoietic Growth Factors After Stem Cell Transplantation: Does It Pay
  Journal of Pediatric Hematology/Oncology, 2001
• 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
  Journal of Clinical Oncology, 2000
• Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia
  Journal of Clinical Oncology, 2000
• Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: A case for prospective economic analysis in cooperative group trials
  Medical and Pediatric Oncology, 2000
• Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia
  Medical and Pediatric Oncology, 1999
• Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study.
  Journal of Clinical Oncology, 1998
• Human Granulocyte Colony-Stimulating Factor after Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1997
• Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology.
  Journal of Clinical Oncology, 1996
• Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment [see comments]
  Blood, 1992